Urinary citrate support.

Citrate binds calcium in urine and raises urinary citrate, which slows the growth and aggregation of calcium crystals. The potassium salt also raises urine pH, which keeps uric acid in solution.

An alkali load raises urine pH and lifts citrate excretion by reducing how much citrate the tubule reabsorbs. Both changes make urine less prone to hold calcium and oxalate together.

Magnesium binds oxalate in the gut, reducing how much is absorbed, and it also forms soluble complexes with oxalate in urine. Both actions lower the calcium oxalate saturation of urine.

The magnesium binds oxalate while the citrate binds calcium and raises urinary citrate. One salt contributes on both sides of the calcium oxalate balance.

Calcium taken with food binds dietary oxalate in the gut so less oxalate is absorbed and later excreted in urine. Timing matters, since calcium away from food does not bind the oxalate load.

The calcium binds oxalate in the gut while the citrate counterion raises urinary citrate rather than adding acid load. That combination is the usual choice where urinary calcium chemistry is the concern.

Alanine glyoxylate aminotransferase uses pyridoxal 5-phosphate to convert glyoxylate into glycine. With adequate B6 more glyoxylate takes that route instead of being oxidised to oxalate.

Extracts of Phyllanthus niruri interfere with calcium oxalate crystal nucleation and aggregation in laboratory work. The described mechanism is crystallisation inhibition rather than mineral binding.

A portion of ingested ascorbate is converted to oxalate and excreted in urine, and the effect scales with dose. Large ascorbate intakes work against a formula aimed at lowering urinary oxalate.

Sodium and calcium are reabsorbed together in the proximal tubule, so a high sodium load pushes more calcium into urine. That raises urinary calcium regardless of how much calcium is eaten.

Vitamin D raises intestinal calcium absorption, and above a person's need the surplus appears as higher urinary calcium. That runs against the aim of lowering calcium saturation in urine.

Cranberry carries oxalate and tends to lower urine pH, which raises urinary oxalate and keeps uric acid less soluble. It pulls in the opposite direction to a citrate and alkali approach.

Spinach is one of the densest dietary sources of oxalate, and the absorbed fraction appears in urine. Taken alongside it, a formula aimed at urinary oxalate is working against a large incoming load.

Pyridoxal-5-phosphate is the cofactor that lets alanine:glyoxylate aminotransferase move glyoxylate to glycine in the liver peroxisome. When that step runs, less glyoxylate is oxidised onward to oxalate, which is the main organic component of urinary crystals. This is cofactor biochemistry rather than an outcome measured in a trial, and the B6 form already stored on this page covers the same vitamin in its activated salt.

Calcium taken with a meal binds oxalate in the intestinal lumen and forms a poorly soluble complex that leaves in the stool rather than being absorbed. The timing carries the whole effect: with food it lowers oxalate absorption, away from food it does not do the same job. Calcium carbonate needs stomach acid to dissolve, so it is a with-meal salt by chemistry as well as by intent.

An oral alkali load reduces proximal tubule citrate reabsorption, so more citrate reaches the urine, and it raises urinary pH. Citrate in urine complexes calcium and keeps it in solution. The sodium load itself pushes calcium excretion the other way, which is why potassium salts are the more usual alkali in this setting. Both facts belong on the label.

Several gut organisms, Oxalobacter formigenes most studied among them, degrade oxalate in the intestinal lumen before it can be absorbed. Reviews of the gut-kidney oxalate axis describe this as a real degradative capacity that varies widely between people. What is not settled is whether a commercial probiotic reliably colonises or reproduces that capacity, so read this as mechanism with a plausible route rather than a measured urinary result.

Some lactic acid bacteria carry oxalate decarboxylase or oxalyl-CoA decarboxylase activity and can lower oxalate in culture. Reviews of the gut-kidney axis list them among candidate organisms alongside the dedicated oxalate degraders. The human urinary evidence for any single strain is thin, so this sits at the level of a mechanistic candidate.

Fermentable fructans feed colonic bacteria and shift short-chain fatty acid production, which is the substrate side of any microbial oxalate handling. The link from a prebiotic to a urinary oxalate figure runs through several unmeasured steps. This is a substrate rationale, not a measured urinary endpoint.

A randomised crossover trial tested apple cider vinegar against urine chemistry endpoints in people who form urinary crystals. Acetic acid is metabolised to bicarbonate, which is the proposed route to a higher urinary pH and citrate. The trial measured urine chemistry, which is a set of markers rather than a clinical outcome.

Citrate from citrus complexes calcium in urine and inhibits the nucleation and growth of calcium oxalate crystals. A multicentre randomised controlled trial of a lime-based supplement reported fewer calcium oxalate stone recurrences than the comparison arm. Citrus citrate and the potassium citrate salt already stored here work through the same urinary chemistry, with different accompanying cations.

Tea leaf carries appreciable oxalate, and concentrated leaf extracts can carry it forward depending on how the extract was made. That runs against the intent of a low-oxalate intake plan. Extract oxalate content is rarely on a label and varies by process, so the honest position is to ask the supplier rather than assume either way.